Akums Drugs and Pharmaceuticals Limited Financial Ratios
AKUMS · Healthcare · Current price ₹731
P/E ratio
43.9x
P/B ratio
3.6x
ROE
7.7%
ROCE
13.7%
Debt / Equity
0.05
Dividend yield
0.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 43.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 7.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 13.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.05 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Akums Drugs and Pharmaceuticals Limited's latest numbers.
Akums Drugs and Pharmaceuticals Limited profitability
Akums Drugs and Pharmaceuticals Limited generates a return on equity of 7.7% and a return on capital employed of 13.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.05 and a P/E of 43.9x, Akums Drugs and Pharmaceuticals Limited is conservatively financed. Our overall business-quality score for the company is 4.4 / 10.
Understand the ratios
More on Akums Drugs and Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.